0.5014
Rani Therapeutics Holdings Inc Aktie (RANI) Neueste Nachrichten
Rani Therapeutics Holdings Inc. Stock Analysis and ForecastFree Trend-Following Techniques - Autocar Professional
Is Rani Therapeutics Holdings Inc. a good long term investmentConsistent triple-digit returns - Autocar Professional
What analysts say about Rani Therapeutics Holdings Inc. stockConsistently exceptional gains - Autocar Professional
What drives Rani Therapeutics Holdings Inc. stock priceBreakthrough investment results - jammulinksnews.com
Why Rani Therapeutics Holdings Inc. stock attracts strong analyst attentionDaily Swing Candidates - Newser
Rani Therapeutics Announces New Securities Purchase Agreement - The Globe and Mail
Rani Therapeutics Shares Surge After ENDO 2025 Presentation Announcement - MSN
Rani Therapeutics stock plunges after $3 million registered direct offering By Investing.com - Investing.com India
Rani Therapeutics Shares Drop Sharply Following $3 Million Direct Offering Announcement - MSN
What makes Rani Therapeutics Holdings Inc. stock price move sharplyLong Term Low Risk Growth - Newser
Rani Therapeutics stock plunges after $3 million registered direct offering - Investing.com
How Rani Therapeutics Holdings Inc. stock performs during market volatility10x Return With Managed Risk - Newser
Rani Therapeutics secures $3 million through registered direct offering By Investing.com - Investing.com South Africa
Rani Therapeutics secures $3 million through registered direct offering - Investing.com
Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering - The Manila Times
Rani Therapeutics Secures $3M Financing Deal: Biotech Firm Prices Shares at $0.40 in Strategic Offering - Stock Titan
Pre-market Movers: KAPA, CYCC, SONN, RANI... - RTTNews
Rani Therapeutics (NASDAQ:RANI) Shares Up 8.4% – Here’s What Happened - Defense World
The Psychology of Rani Therapeutics Holdings Inc Inc. (RANI) Price Performance: Understanding Market Sentiment - investchronicle.com
Rani Therapeutics stock soars after announcing ENDO 2025 presentation - Investing.com
Rani Therapeutics stock soars after announcing ENDO 2025 presentation By Investing.com - Investing.com Canada
Rani Therapeutics Surges on Game-Changing Oral Drug Delivery News - RagingBull
Why Datavault AI Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Rani Therapeutics to Present Preclinical Data on RaniPill® Capsule at ENDO 2025 Conference - Nasdaq
Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery - GlobeNewswire
Revolutionary Oral GLP-1 Delivery System Matches Injectable Performance: RaniPill's Game-Changing Study Results - Stock Titan
Logitech Announces Date for Release of First Quarter Results for Fiscal Year 2026 - The Globe and Mail
Rani Therapeutics Holdings, Inc.(NasdaqGM:RANI) added to Russell Microcap Growth Index - MarketScreener
Rani Therapeutics Faces Nasdaq Compliance Deadline for Minimum Bid Price Requirement - AInvest
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):